Tuesday, 17 November 2026European Markets

ABL Diagnostics Stock Went Down By Over 18% In The Last 5 Sessions

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(vianews) - shares of abl diagnostics (cac 40: abld.pa) slid by a staggering 18.92% in 5 sessions from €11.84 to €9.60 at 13:40 est on wednesday, after five successive sessions in a row of losses. cac 40 is dropping 3.4% to €6,898.42, following the last session's upward trend.

about abl diagnostics

abl diagnostics société anonyme does not have significant operations. the company was formerly known as etablissements fauvet girel and changed its name to abl diagnostics société anonyme in april 2022. the company is headquartered in paris, france. abl diagnostics société anonyme is a subsidiary of advanced biological laboratories (abl) s.a.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, abl diagnostics's stock is considered to be overbought (>=80).

more news about abl diagnostics (abld.pa).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 15 Mar 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›